The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Clinical trial NCT05829057 · UNKNOWN

Trial details

NCT number: NCT05829057
Sponsor: Zhejiang University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Esophagus Cancer Bladder Cancer Liver Cancer Ovarian Cancer Small-cell Lung Cancer

Start date: 2023-05-23
Primary completion: 2024-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.